Indivior Pharmaceuticals, Inc. (INDV)
35.71
+0.33
(+0.93%)
USD |
NASDAQ |
Oct 02, 16:00
35.35
-0.36
(-1.01%)
After-Hours: 20:00
Indivior Pharmaceuticals Market Cap : 4.214B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 4.214B |
| October 01, 2026 | 4.175B |
| September 30, 2026 | 4.230B |
| September 29, 2026 | 4.318B |
| September 28, 2026 | 4.352B |
| September 25, 2026 | 4.227B |
| September 24, 2026 | 4.248B |
| September 23, 2026 | 4.237B |
| September 22, 2026 | 4.270B |
| September 21, 2026 | 4.193B |
| September 18, 2026 | 4.116B |
| September 17, 2026 | 4.211B |
| September 16, 2026 | 4.053B |
| September 15, 2026 | 4.038B |
| September 14, 2026 | 4.067B |
| September 11, 2026 | 4.070B |
| September 10, 2026 | 4.072B |
| September 09, 2026 | 4.103B |
| September 08, 2026 | 4.050B |
| September 04, 2026 | 4.123B |
| September 03, 2026 | 4.110B |
| September 02, 2026 | 4.136B |
| September 01, 2026 | 4.078B |
| August 31, 2026 | 4.122B |
| August 28, 2026 | 4.115B |
| Date | Value |
|---|---|
| August 27, 2026 | 4.165B |
| August 26, 2026 | 4.227B |
| August 25, 2026 | 4.244B |
| August 24, 2026 | 4.269B |
| August 21, 2026 | 4.351B |
| August 20, 2026 | 4.458B |
| August 19, 2026 | 4.607B |
| August 18, 2026 | 4.653B |
| August 17, 2026 | 4.611B |
| August 14, 2026 | 4.603B |
| August 13, 2026 | 4.510B |
| August 12, 2026 | 4.570B |
| August 11, 2026 | 4.535B |
| August 10, 2026 | 4.539B |
| August 07, 2026 | 4.581B |
| August 06, 2026 | 4.563B |
| August 05, 2026 | 4.570B |
| August 04, 2026 | 4.307B |
| August 03, 2026 | 4.410B |
| July 31, 2026 | 4.721B |
| July 30, 2026 | 4.746B |
| July 29, 2026 | 4.732B |
| July 28, 2026 | 5.001B |
| July 27, 2026 | 4.884B |
| July 24, 2026 | 4.944B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Supernus Pharmaceuticals, Inc. | 2.465B |
| Eli Lilly & Co. | 1.076T |
| Bristol Myers Squibb Co. | 124.93B |
| Liquidia Corp. | 2.552B |
| Harmony Biosciences Holdings, Inc. | 2.304B |
Market Cap Related Metrics
| PE Ratio | 12.68 |
| PS Ratio | 3.398 |
| PEG Ratio | 0.0551 |
| Price | 35.71 |
| Earnings Yield | 7.88% |
| Operating PE Ratio | 8.508 |
| Normalized PE Ratio | 10.01 |